Natera (NTRA) Change in Accured Expenses (2014 - 2026)
Natera's (NTRA) quarterly Change in Accured Expenses came in at $12.1 million in Q1 2026, down 28.94% YoY from $17.0 million in Q1 2025, and little changed on a QoQ basis from $12.1 million in Q4 2025.
Natera (NTRA) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Natera (NTRA) has 13 years of Change in Accured Expenses data on file, last reported at $12.1 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 28.94% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.3 million (up 876.14% YoY) and the FY2025 annual result came in at $60.3 million, up 1045.25% from the prior year.
- Change in Accured Expenses was little changed at $12.1 million in Q1 2026, from $12.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $28.1 million in Q2 2023 to a low of -$29.3 million in Q2 2022.
- A 5-year average of $4.7 million and a median of $12.1 million in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 607.93% — and 2023, when it jumped 596.13%.
- Tracing NTRA's Change in Accured Expenses over 5 years: stood at $1.8 million in 2022, then jumped by 596.13% to $12.4 million in 2023, then jumped by 30.04% to $16.2 million in 2024, then slipped by 25.27% to $12.1 million in 2025, then advanced by 0.3% to $12.1 million in 2026.
- The last three Change in Accured Expenses figures came in at $12.1 million (Q1 2026), $12.1 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | -48.00 Mn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | - |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 12.11 Mn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 142.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -27.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.11 Mn |
| Mar 31, 2026 | 12.11 Mn |
| Dec 31, 2025 | 12.07 Mn |
| Dec 31, 2025 | 12.07 Mn |
| Sep 30, 2025 | 7.74 Mn |
| Sep 30, 2025 | 7.74 Mn |
| Jun 30, 2025 | 23.43 Mn |
| Jun 30, 2025 | 23.43 Mn |
| Mar 31, 2025 | 17.04 Mn |
| Mar 31, 2025 | 17.04 Mn |
| Dec 31, 2024 | 16.15 Mn |
| Dec 31, 2024 | 16.15 Mn |
| Sep 30, 2024 | -11.93 Mn |
| Sep 30, 2024 | -11.93 Mn |
| Jun 30, 2024 | -28.39 Mn |
| Jun 30, 2024 | -28.39 Mn |
| Mar 31, 2024 | 17.79 Mn |
| Mar 31, 2024 | 17.79 Mn |
| Dec 31, 2023 | 12.42 Mn |
| Dec 31, 2023 | 12.42 Mn |